The company’s innovations have not gone unnoticed. AI Medical Service was featured in 
SONIRE’s approach, which utilizes cavitation to enhance treatment accuracy, has been recognized by the U.S. FDA as a breakthrough device. The company is currently conducting a world-first randomized trial to further validate the efficacy of their technology. As CEO Satoh Tohru notes, the goal is to offer a more effective and safer cancer treatment to patients worldwide.
These Japanese startups are not only advancing medical technology but also providing hope for millions of cancer patients globally. As the world braces for a surge in cancer cases, innovations from companies like AI Medical Service and SONIRE Therapeutics could be pivotal in changing the landscape of cancer treatment.
Los Alamitos at a Breaking Point After 18 Racehorse Deaths Spur Emergency Safety Demands
Los Alamitos Race Course is facing its most serious crisis in years after 18 horses died in 2025, prompting regulators to warn the track that its racing license is at risk without immediate safety reforms. Following three catastrophic injuries in a single day, the California Horse Racing Board has ordered urgent changes—including more veterinarians, stricter medication rules, and enhanced on‑track medical support—as pressure mounts for stronger oversight in a sport already under national scrutiny.
